Although it is one of the most common inactivated tumor suppressor genes in cancers, the signal amplitude of these zones is in high consistency with cancer types (gliomas, lung cancers, melanoma, and breast), where the loss of PTEN is especially frequent and crucial (Milella et al., 2015; Fusco et al., 2020). This evidence concerns the gene PTEN and lung cancer.